Acute kidney injury after placement of an antibiotic-impregnated cement spacer during revision total knee arthroplasty

J Arthroplasty. 2012 Jun;27(6):1221-7.e1-2. doi: 10.1016/j.arth.2011.12.005. Epub 2012 Feb 7.

Abstract

We performed a retrospective cohort study of 84 patients to determine the incidence and predictors of acute kidney injury after antibiotic-impregnated cement spacer (ACS) placement for infected total knee arthroplasties. Acute kidney injury was defined as a more than 50% rise in serum creatinine from a preoperative baseline to a level greater than 1.4 mg/dL within 90 days postoperatively. Total incidence was 17% (n = 14; 95% confidence interval [CI], 10%-26%), and acute kidney injury was significantly associated with ACS tobramycin dose as both a dichotomous variable (>4.8 g; odds ratio, 5.87; 95% CI, 1.43-24.19; P = .01) and linear variable (odds ratio, 1.24 for every 1-g increase; 95% CI, 1.00-1.52; P = .049). Routine monitoring of serum creatinine and measurement of serum aminoglycoside levels in response to a threshold creatinine rise may be warranted after the placement of an aminoglycoside-containing ACS.

MeSH terms

  • Acute Kidney Injury / blood
  • Acute Kidney Injury / chemically induced*
  • Acute Kidney Injury / epidemiology*
  • Aged
  • Aminoglycosides / adverse effects
  • Aminoglycosides / blood
  • Aminoglycosides / therapeutic use
  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Arthroplasty, Replacement, Knee / instrumentation*
  • Arthroplasty, Replacement, Knee / methods
  • Bone Cements / adverse effects*
  • Cohort Studies
  • Creatinine / blood
  • Female
  • Humans
  • Incidence
  • Kidney / physiopathology
  • Knee Prosthesis / adverse effects*
  • Male
  • Middle Aged
  • Prosthesis-Related Infections / prevention & control*
  • Prosthesis-Related Infections / surgery
  • Reoperation
  • Retrospective Studies
  • Tobramycin / adverse effects
  • Tobramycin / therapeutic use

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Bone Cements
  • Creatinine
  • Tobramycin